ConductScience.org, home

Paper40584

Effects of oral H1 and H2 receptor antagonists in asthma.

Leopold JD and 2 others. Br J Clin Pharmacol, 1979. Cited by 19 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effects of oral H1 and H2 receptor antagonists in asthma. Papers, record 40584. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40584

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of oral H1 and H2 receptor antagonists in asthma.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.72
iCite
Revised in PubMed
2019-05-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Leopold JDJ D
2Hartley JPJ P
3Smith APA P

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AsthmaMajor topic
Histamine H1 AntagonistsMajor topic
Histamine H2 AntagonistsMajor topic
Adolescent
Adult
Double-Blind Method
Forced Expiratory Flow Rates
Humans
Middle Aged
Peak Expiratory Flow Rate
Physical Exertion

Source PubMed

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,145,535Comparison of the bronchial response to running and cycling in asthma using an improved definition of the response to work.Thorax1975https://conductscience.org/library/papers/1145535PubMed
213,094Bronchodilating activity of an H1 blocker, chlorpheniramine.J Allergy Clin Immunol1977https://conductscience.org/library/papers/13094PubMed
449,311Sequential analysis of the allergic response: cyclic AMP, calcium and histamine.Int Arch Allergy Appl Immunol1975https://conductscience.org/library/papers/49311PubMed
5629,482H2 receptor mediated inhibition of immediate type hypersensitivity reactions in vivo.Am Rev Respir Dis1978https://conductscience.org/library/papers/629482PubMed
6694,800Bronchodilatation after inhalation of the antihistamine clemastine.Thorax1978https://conductscience.org/library/papers/694800PubMed
7915,147The relationship of plasma histamine to the activity of bronchial asthma.J Allergy Clin Immunol1977https://conductscience.org/library/papers/915147PubMed

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
6,150,725H2-receptor blockade and exercise-induced asthma.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6150725PubMed
6,127,438H1-receptor antagonists: comparative pharmacology and clinical use.Klin Wochenschr1982https://conductscience.org/library/papers/6127438PubMed
3,899,673Protective effect by UCB JO28 against histamine and methacholine induced bronchial hyperreactivity.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3899673PubMed
2,408,646Ranitidine does not potentiate mediator release from human lung in vitro.Br J Clin Pharmacol1985https://conductscience.org/library/papers/2408646PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40584

GET https://conductscience.org/api/papers/v1/40584/authors